Browsing byAuthorLaufs, U

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 18 of 18
Issue DateTitleAuthor(s)
2019-01Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk.Katzmann, JL; Mahfoud, F; Böhm, M; Schulz, M; Laufs, U
2020-10Development and implementation of blood pressure screening and referral guidelines for German community pharmacists.Schulz, M; Griese-Mammen, N; Schumacher, PM; Strauch, D; Freudewald, L; Said, A; Tsuyuki, RT; Laufs, U; Kintscher, U; Böhm, M; Mahfoud, F
2017-12-01Do patients with diabetes type 2 or chronic heart failure understand a medication plan?Botermann, L; Wachter, A; Monzel, K; Krueger, K; Ewen, S; Mahfoud, F; Griese-Mammen, N; Schulz, M; Laufs, U
2016-10Evaluating patients' comprehensibility of a standardized medication plan.Botermann, L; Monzel, K; Krueger, K; Eickhoff, C; Wachter, A; Kloft, C; Laufs, U; Schulz, M
2023-11-27Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study.Kunz, M; Götzinger, F; Jacobs, CM; Lauder, L; Ukena, C; Meyer, MR; Laufs, U; Schulz, M; Böhm, M; Mahfoud, F
2021-10Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany.Rudolph, UM; Enners, S; Kieble, M; Mahfoud, F; Böhm, M; Laufs, U; Schulz, M
2018-01In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.Krueger, K; Griese-Mammen, N; Schubert, I; Kieble, M; Botermann, L; Laufs, U; Kloft, C; Schulz, M
2021Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial.Schumacher, PM; Griese-Mammen, N; Schneider, J; Laufs, U; Schulz, M
2020-03Letter on 'Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial': reply.Schulz, M; Griese-Mammen, N; Böhm, M; Laufs, U
2016-10-01Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.Schulz, M; Krueger, K; Schuessel, K; Friedland, K; Laufs, U; Mueller, WE; Ude, M
2016Medication knowledge of patients hospitalized for heart failure at admission and after discharge.Custodis, F; Rohlehr, F; Wachter, A; Böhm, M; Schulz, M; Laufs, U
2023-05-20Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy.Schulz, M; Laufs, U
2018-09PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study.Laufs, U; Griese-Mammen, N; Krueger, K; Wachter, A; Anker, SD; Koehler, F; Rettig-Ewen, V; Botermann, L; Strauch, D; Trenk, D; Böhm, M; Schulz, M
2022-12Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials.Abdin, A; Schulz, M; Riemer, U; Hadëri, B; Wachter, R; Laufs, U; Bauersachs, J; Kindermann, I; Vukadinović, D; Böhm, M
2020-07-23The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial.Schulz, M; Griese-Mammen, N; Schumacher, PM; Anker, SD; Koehler, F; Ruckes, C; Rettig-Ewen, V; Wachter, R; Trenk, D; Böhm, M; Laufs, U
2022Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021.Katzmann, JL; Kieble, M; Enners, S; Böhm, M; Mahfoud, F; Laufs, U; Schulz, M
2022-02-27Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia.Mahfoud, F; Kieble, M; Enners, S; Kintscher, U; Laufs, U; Böhm, M; Schulz, M
2021-11Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.Enners, S; Gradl, G; Kieble, M; Böhm, M; Laufs, U; Schulz, M